Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report. Intergroup Trial of Adjuvant Chemotherapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback